Skip to main content

Table 3 The results of uivariate analysis

From: The association between systemic immune-inflammation index and in vitro fertilization outcomes in women with polycystic ovary syndrome: a cohort study

No. of available embryos

Statistics

β(95%CI), P value

Age

28.31 ± 3.17

-0.05 (-0.13, 0.04), 0.298

Duration of infertility(y)

3.29 ± 2.05

-0.10 (-0.24, 0.03), 0.133

BMI(Kg/m2)

  < 18.5

38 (3.93%)

0

 18.5–25

547 (56.63%)

-0.35 (-1.78, 1.07), 0.626

 25–30

282 (29.19%)

-1.39 (-2.86, 0.07), 0.063

  ≥ 30

99 (10.25%)

-2.71 (-4.33, -1.08), 0.001

AMH(ng/ml)

 Low (< 7.44)

321 (33.23%)

0

 Middle (7.44–10.66)

323 (33.44%)

1.43 (0.75, 2.10), < 0.0001

 High (≥ 10.66)

322 (33.33%)

1.98 (1.30, 2.66), < 0.0001

 Basal FSH(IU/L)

6.64 ± 2.02

-0.20 (-0.34, -0.06), 0.004

 Basal E2(pg/mL)

49.07 ± 57.43

0.00 (-0.00, 0.01), 0.861

 Basal LH(IU/L)

7.63 ± 4.20

0.12 (0.06, 0.19), 0.0003

 AFC

15.48 ± 4.96

0.40 (0.35, 0.45), < 0.0001

 Starting dose of Gn(IU)

189.50 ± 36.14

-0.02 (-0.03, -0.01), < 0.0001

 Duration of Gn(IU)

9.25 ± 1.74

-0.21 (-0.37, -0.05), 0.011

 SII

1100.36 ± 463.46

0.00 (-0.00, 0.00), 0.569

SII quartile

 Q1

242 (25.05%)

0

 Q2

241 (24.95%)

0.86 (0.08, 1.64), 0.031

 Q3

241 (24.95%)

0.76 (-0.02, 1.54), 0.057

 Q4

242 (25.05%)

0.11 (-0.68, 0.89), 0.787

 SII quartile continuous

1.50 ± 1.12

0.02 (-0.23, 0.27), 0.860

 Log SII

6.92 ± 0.41

0.27 (-0.42, 0.95), 0.445

  1. Data is represented as β(95%CI), P value
  2. SII: Quantile 1 Quantile 2 Quantile 3 Quantile 4
  3. Abbreviations: SII Systemic immune-inflammation index, BMI Body mass index, FSH Follicle-stimulating hormone, LH Luteinizing hormone, T Testosterone, AMH Anti-müllerian hormone, P Progesterone, AFC Antral follicle count, Gn Gonadotropin, GnRH-ant Gonadotropin releasing hormone antagonist; HCG human chorionic gonadotropin